Literature DB >> 25992384

The real difficulty in improving concordance of clinical practice with guidelines.

Nengliang Yao1, Abram Recht1.   

Abstract

Year:  2015        PMID： 25992384      PMCID： PMC4416950          DOI： 10.3978/j.issn.2305-5839.2015.03.51

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Clinical, sociodemographic, and service provider determinants of guideline concordant colorectal cancer care for Appalachian residents.

Authors:  Steven T Fleming; Heath B Mackley; Fabian Camacho; Eric E Seiber; Niraj J Gusani; Stephen A Matthews; Jason Liao; Tse-Chuan Yang; Wenke Hwang; Nengliang Yao
Journal:  J Rural Health       Date:  2013-06-26       Impact factor: 4.333

2.  Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer.

Authors:  Grace L Smith; Ying Xu; Thomas A Buchholz; Sharon H Giordano; Jing Jiang; Ya-Chen Tina Shih; Benjamin D Smith
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

3.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.

Authors:  Csaba Polgár; János Fodor; Tibor Major; Zoltán Sulyok; Miklós Kásler
Journal:  Radiother Oncol       Date:  2013-06-03       Impact factor: 6.280

4.  Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.

Authors:  Jennifer Wong; Laura D'Alimonte; Jan Angus; Larry Paszat; Kelly Metcalfe; Tim Whelan; Hilary Llewellyn-Thomas; Eiran Warner; Edmee Franssen; Ewa Szumacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

Review 5.  Accelerated partial breast irradiation: the need for well-defined patient selection criteria, improved volume definitions, close follow-up and discussion of salvage treatment.

Authors:  Elizabeth C Moser; Conny Vrieling
Journal:  Breast       Date:  2012-11-03       Impact factor: 4.380

6.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Authors:  Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

7.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

8.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Authors:  Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-15       Impact factor: 7.038

9.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Authors:  Umberto Veronesi; Roberto Orecchia; Patrick Maisonneuve; Giuseppe Viale; Nicole Rotmensz; Claudia Sangalli; Alberto Luini; Paolo Veronesi; Viviana Galimberti; Stefano Zurrida; Maria Cristina Leonardi; Roberta Lazzari; Federica Cattani; Oreste Gentilini; Mattia Intra; Pietro Caldarella; Bettina Ballardini
Journal:  Lancet Oncol       Date:  2013-11-11       Impact factor: 41.316

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.